SkyePharma Exchanges Share Of Phase III Risk, Reward For $30M Jan. 17, 2001 By Nuala Moran No Comments
Avidex Completes £10M Funding For Programs In T-Cell Receptors Jan. 17, 2001 By Nuala Moran No Comments
Cambridge Drug Eyes Licensing Deals Following £7.5M Financing Jan. 17, 2001 By Nuala Moran No Comments
Oxford BioMedica Moving To LSE Following TroVax Trial Approval Jan. 10, 2001 By Nuala Moran No Comments
Oxford BioMedica Moving To LSE Following TroVax Trial Approval Jan. 10, 2001 By Nuala Moran No Comments
Oxxon Plans Moves Into Phase II Following £4.7M Private Funding Jan. 3, 2001 By Nuala Moran No Comments
